There are no official guidelines to assist in answering this question. I will search for relevant research papers instead.
From the Research
Treatment for Hyaline Casts in Individuals with Alcohol Use Disorder (AUD)
There is no direct evidence on the treatment of hyaline casts in individuals with AUD. However, the following information is available on the treatment of AUD:
- The US Food and Drug Administration has approved four medications for the treatment of AUD: disulfiram, naltrexone, acamprosate, and extended-release injectable naltrexone [ 1, 2 ].
- Naltrexone has been shown to reduce the likelihood of a return to any drinking by 5% and binge-drinking risk by 10% [ 1 ].
- Baclofen is considered a first-line pharmacological agent for the long-term management of AUD in patients with alcoholic liver disease [ 3 ].
- Psychosocial interventions, such as motivation enhancement therapy and cognitive behavioral therapy, are also beneficial in the treatment of AUD [ 3, 4 ].
Key Considerations
- Patients with AUD should be screened for the presence of the disorder and given brief counseling and prescribed a first-line medication or referred for a more intensive psychosocial intervention [ 1 ].
- Treatment retention and follow-up are vital and can positively influence outcomes [ 3 ].
- Special populations, such as pregnant and nursing patients, patients experiencing homelessness, and patients with poor treatment response, require unique considerations and tailored approaches [ 2 ].
Some potential treatments for AUD include: